Eduardo Reategui, PhD
College of Engineering
Chemical & Biomolecular Engineering
Molecular Biology and Cancer Genetics
The Reátegui research group focuses on the development of microtechnology platforms for the isolation and characterization of circulating tumor biomarkers for cancer diagnostics and therapeutics. Circulating biomarkers are currently extensively studied in the cancer research field because of their potential to transform the way cancer is diagnosed and treated. Our work primarily focuses on circulating tumor cells (CTCs) and tumor-specific extracellular vesicles (EVs) from cancer patients.